Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference - Plus Therapeutics (NASDAQ:PSTV)

Marc Hedrick, President & CEO of Plus Therapeutics (NASDAQ: PSTV), was a guest on Benzinga’s All-Access.

Related Keywords

San Francisco ,California ,United States ,Marc Hedrick ,Society For Neuro ,Plus Therapeutics ,Neuro Oncology Conference ,Hans Reniers ,